Fortress Biotech
Price & Volume
Stats
See more52W Range | $1.33-$4.53 |
Market Cap | $133.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $62.3M |
Revenue Growth (YoY) | 20.5% |
Gross Profit (12 Mos) | $19.9M |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 24 days ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
Yahoo Finance • 2 months ago
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Yahoo Finance • 2 months ago
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Yahoo Finance • 2 months ago
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
About
CEO | Dr. Lindsay Allan Rosenwald M.D. |
CFO | Mr. David Jin |
Address | 1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 101 |
